| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |